Teva Pharmaceutical Industries
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- -
- Employees
- 37.8K
- Market Cap
- $21.2B
- Introduction
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Amid Shortages, US Allows Expanded Production of ADHD Drug Vyvanse
The DEA approved Takeda Pharmaceuticals to increase Vyvanse production by 24% to address ongoing ADHD drug shortages, with a 13,478-pound increase including 3434 pounds for domestic and 10,313 pounds for foreign demand.
Amid Shortages, U.S. Allows Expanded Production of ADHD Drug Vyvanse
The U.S. DEA approved Takeda Pharmaceuticals to increase Vyvanse production by 24% due to ongoing ADHD drug shortages, with 13,478 pounds allocated for domestic and foreign demand.
© Copyright 2024. All Rights Reserved by MedPath